Global Single Cell Market Analysis 2018-2025 - Focus on IVF, Cancer, Immunology, Stem Cell, Non-invasive Prenatal Diagnosis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The “Single Cell Analysis Market Size, Share & Trends Analysis Report By Application (IVF, Cancer, Immunology, Stem Cell, Non-invasive Prenatal Diagnosis), By Product, By Region, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.
The global single cell analysis market size is expected to reach USD 5.9 billion by 2025.
It is projected to expand at a CAGR of 17.3% during the forecast period. High demand for early detection techniques and rapid technological advancements are creating a significant demand for single cell analysis. This technique is used in genomic, transcriptomic, proteomics, and epigenetic studies.
Single cell analytics helps assess cellular heterogeneity and aids in analysis of pathways and processes at a molecular level. It can be performed with samples as small as a single cell. Its current applications in diagnostics include genetic analysis, prenatal screening, cancer genomics, and neurological therapeutics.
Rising prevalence of chronic diseases is anticipated to drive demand for molecular assay services, subsequently leading to the growth of this sector. Single cell analysis plays an important role in risk management related to organ transplants, cancer, heart failure, renal diseases, and infectious disease testing by performing fast, accurate, and effective tests.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Single Cell Analysis Market Variables, Trends & Scope
Chapter 4 Single Cell Analysis Market: Product Estimates & Trend Analysis
Chapter 5 Single Cell Analysis Market: Application Estimates & Trend Analysis
Chapter 6 Single Cell Analysis Market: Regional Estimates & Trend Analysis, by Product & Application Type
Chapter 7 Competitive LandscapeThermo Fisher Scientific, Inc. Qiagen N.V. Bio-Rad Laboratories, Inc. Illumina, Inc. Merck Millipore Becton Dickinson & Company (BD)
For more information about this report visit https://www.researchandmarkets.com/research/22frhj/global_single?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005661/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH OTHER HEALTH OTHER SCIENCE SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/23/2018 02:12 PM/DISC: 08/23/2018 02:12 PM